Mimio Health

📍 San Francisco, United States🗓 Founded 2020👥 4 employees💰 Last funded Jan 2023
Biotechnology Research🌐 mimiohealth.com
Website LinkedIn
Mimio Health is a nutraceutical company dedicated to the research and production of the worlds first fasting mimetic supplement. Our supplement was designed from clinical research to replicate the cellular health benefits and lifespan-promoting effects of fasting without the need to fast. Through years of research into human fasting we have uncovered a conserved metabolic program for cellular health and regeneration that underpins the beneficial effects of fasting. Our patent-pending fasting mimetic forumuation uses a rigorously selected combination of the same bioactive human metabolites that induce this regenerative "bio-program" to replicate the body’s natural response to fasting without having to fast. We have shown that our fasting mimetic is capable of extending the lifespan of model organisms by 96% and has powerful anti-inflammatory and antioxidant effects in human cells that could combat age-associated chronic inflammation and cellular damage allowing our customers to live longer, healthier lives.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mimio Health?
Mimio Health has 1 investors on record on gritt.io, 1 mid-stage.
When did Mimio Health last raise funding?
The most recent investment in Mimio Health recorded on gritt.io was in January 2023.
When was Mimio Health founded?
Mimio Health was founded in 2020.
What industry is Mimio Health in?
Mimio Health operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mimio Health based?
Mimio Health is headquartered in San Francisco, United States.